109 related articles for article (PubMed ID: 27394650)
1. Optic nerve integrity as a visuospatial cognitive predictor in Parkinson's disease.
Lee JJ; Shin NY; Lee Y; Lee SK; Sohn YH; Lee PH
Parkinsonism Relat Disord; 2016 Oct; 31():41-45. PubMed ID: 27394650
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal diffusion tensor imaging changes in early Parkinson's disease: ICICLE-PD study.
Minett T; Su L; Mak E; Williams G; Firbank M; Lawson RA; Yarnall AJ; Duncan GW; Owen AM; Khoo TK; Brooks DJ; Rowe JB; Barker RA; Burn D; O'Brien JT
J Neurol; 2018 Jul; 265(7):1528-1539. PubMed ID: 29696499
[TBL] [Abstract][Full Text] [Related]
3. Correlation of dopaminergic terminal dysfunction and microstructural abnormalities of the basal ganglia and the olfactory tract in Parkinson's disease.
Scherfler C; Esterhammer R; Nocker M; Mahlknecht P; Stockner H; Warwitz B; Spielberger S; Pinter B; Donnemiller E; Decristoforo C; Virgolini I; Schocke M; Poewe W; Seppi K
Brain; 2013 Oct; 136(Pt 10):3028-37. PubMed ID: 24014521
[TBL] [Abstract][Full Text] [Related]
4. DTI correlates of distinct cognitive impairments in Parkinson's disease.
Zheng Z; Shemmassian S; Wijekoon C; Kim W; Bookheimer SY; Pouratian N
Hum Brain Mapp; 2014 Apr; 35(4):1325-33. PubMed ID: 23417856
[TBL] [Abstract][Full Text] [Related]
5. Associations between mobility, cognition and callosal integrity in people with parkinsonism.
Fling BW; Dale ML; Curtze C; Smulders K; Nutt JG; Horak FB
Neuroimage Clin; 2016; 11():415-422. PubMed ID: 27104136
[TBL] [Abstract][Full Text] [Related]
6. Microstructural white matter alterations in patients with drug induced parkinsonism.
Lee Y; Ho Choi Y; Lee JJ; Lee HS; Sohn YH; Lee JM; Lee PH
Hum Brain Mapp; 2017 Dec; 38(12):6043-6052. PubMed ID: 28901627
[TBL] [Abstract][Full Text] [Related]
7. Macular ganglion-cell-complex layer thinning and optic nerve integrity in drug-naïve Parkinson's disease.
Lee JY; Ahn J; Yoon EJ; Oh S; Kim YK; Jeon B
J Neural Transm (Vienna); 2019 Dec; 126(12):1695-1699. PubMed ID: 31630254
[TBL] [Abstract][Full Text] [Related]
8. Asymmetrical diffusion tensor imaging indices of the rostral substantia nigra in Parkinson's disease.
Prakash BD; Sitoh YY; Tan LC; Au WL
Parkinsonism Relat Disord; 2012 Nov; 18(9):1029-33. PubMed ID: 22705126
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal study of cognitive and cerebral metabolic changes in Parkinson's disease.
Baba T; Hosokai Y; Nishio Y; Kikuchi A; Hirayama K; Suzuki K; Hasegawa T; Aoki M; Takeda A; Mori E
J Neurol Sci; 2017 Jan; 372():288-293. PubMed ID: 28017230
[TBL] [Abstract][Full Text] [Related]
10. White matter microstructural integrity and executive function in Parkinson's disease.
Gallagher C; Bell B; Bendlin B; Palotti M; Okonkwo O; Sodhi A; Wong R; Buyan-Dent L; Johnson S; Willette A; Harding S; Ninman N; Kastman E; Alexander A
J Int Neuropsychol Soc; 2013 Mar; 19(3):349-54. PubMed ID: 23321049
[TBL] [Abstract][Full Text] [Related]
11. Neural and dopaminergic correlates of fatigue in Parkinson's disease.
Kang SY; Bang M; Hong JY; Oh J; Kim JS; Han YM; Chang SK; Lee SA; Yoon U; Shin NY
J Neural Transm (Vienna); 2020 Mar; 127(3):301-309. PubMed ID: 31894419
[TBL] [Abstract][Full Text] [Related]
12. Cognitive-nigrostriatal relationships in de novo, drug-naïve Parkinson's disease patients: a [I-123]FP-CIT SPECT study.
Nobili F; Campus C; Arnaldi D; De Carli F; Cabassi G; Brugnolo A; Dessi B; Morbelli S; Sambuceti G; Abbruzzese G; Rodriguez G
Mov Disord; 2010 Jan; 25(1):35-43. PubMed ID: 20058228
[TBL] [Abstract][Full Text] [Related]
13. Transcallosal diffusion tensor abnormalities in predominant gait disorder parkinsonism.
Chan LL; Ng KM; Rumpel H; Fook-Chong S; Li HH; Tan EK
Parkinsonism Relat Disord; 2014 Jan; 20(1):53-9. PubMed ID: 24126023
[TBL] [Abstract][Full Text] [Related]
14. Olfactory impairment in Parkinson's disease and white matter abnormalities in central olfactory areas: A voxel-based diffusion tensor imaging study.
Ibarretxe-Bilbao N; Junque C; Marti MJ; Valldeoriola F; Vendrell P; Bargallo N; Zarei M; Tolosa E
Mov Disord; 2010 Sep; 25(12):1888-94. PubMed ID: 20669268
[TBL] [Abstract][Full Text] [Related]
15. Progression of Regional Microstructural Degeneration in Parkinson's Disease: A Multicenter Diffusion Tensor Imaging Study.
Zhang Y; Wu IW; Tosun D; Foster E; Schuff N;
PLoS One; 2016; 11(10):e0165540. PubMed ID: 27798653
[TBL] [Abstract][Full Text] [Related]
16. Cognitive dysfunction in drug induced parkinsonism (DIP).
Kim YD; Kim JS; Chung SW; Song IU; Yang DW; Hong YJ; Kim YI; Ahn KJ; Kim HT; Lee KS
Arch Gerontol Geriatr; 2011; 53(2):e222-6. PubMed ID: 21163539
[TBL] [Abstract][Full Text] [Related]
17. Cognitive executive impairment and dopaminergic deficits in de novo Parkinson's disease.
Siepel FJ; Brønnick KS; Booij J; Ravina BM; Lebedev AV; Pereira JB; Grüner R; Aarsland D
Mov Disord; 2014 Dec; 29(14):1802-8. PubMed ID: 25284687
[TBL] [Abstract][Full Text] [Related]
18. Fractional Anisotropy and Mean Diffusion as Measures of Dopaminergic Function in Parkinson's Disease: Challenging Results.
Lenfeldt N; Eriksson J; Åström B; Forsgren L; Mo SJ
J Parkinsons Dis; 2017; 7(1):129-142. PubMed ID: 28106567
[TBL] [Abstract][Full Text] [Related]
19. Characterizing Intraorbital Optic Nerve Changes on Diffusion Tensor Imaging in Thyroid Eye Disease Before Dysthyroid Optic Neuropathy.
Lee H; Lee YH; Suh SI; Jeong EK; Baek S; Seo HS
J Comput Assist Tomogr; 2018; 42(2):293-298. PubMed ID: 28937496
[TBL] [Abstract][Full Text] [Related]
20. The role of diffusion tensor imaging and fractional anisotropy in the evaluation of patients with idiopathic normal pressure hydrocephalus: a literature review.
Siasios I; Kapsalaki EZ; Fountas KN; Fotiadou A; Dorsch A; Vakharia K; Pollina J; Dimopoulos V
Neurosurg Focus; 2016 Sep; 41(3):E12. PubMed ID: 27581308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
